BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare

BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare
Brian Gaynor
Fisher & Paykel Healthcare has been a fantastic investment in recent years, particularly during the covid-19 pandemic.At the end of June, the medical supplies company had a share market value of $20.5 billion, making it the first $20 billion NZX company. Its performance during the covid-19 crisis has been amazing with its total market value surging $7.1 billion between Jan. 31 and June 30. This value accretion was greater than the total value of all but four other NZX listed stocks: A2 Milk, Meridian Energy, Auckland International...

More Opinion

Carmageddon: to buy shares, or not to
Opinion

Simon Robertson: Carmageddon: to buy shares, or not to

A basic early investing rule: never own airline or car company shares.

Red tape? More scissors, less string please
Opinion

Deb Te Kawa: Red tape? More scissors, less string please

We need a complete rethink of how we approach regulation in Aotearoa New Zealand.

Deb Te Kawa 13 Dec 2024
Is advertising ready for the giant babushka?
Opinion

Kelly Bennett: Is advertising ready for the giant babushka?

Advertising was built on mergers but has not seen anything like IPG and Omnicom joining.

Kelly Bennett 13 Dec 2024
Microsoft’s shiny new NZ datacentre
Opinion

Peter Griffin: Microsoft’s shiny new NZ datacentre

NZ is a sort of experiment demonstrating the role of high-capacity infrastructure.

Peter Griffin 12 Dec 2024